系统性红斑狼疮心脏损害的临床及危险因素分析

系统性红斑狼疮心脏损害的临床及危险因素分析

论文摘要

目的了解系统性红斑狼疮(systemic lupus erythematosus, SLE)合并心脏损害患者的临床特征,并探讨SLE心脏损害的危险因素及其他脏器损害情况,为SLE合并心脏损害的临床诊疗提供依据。方法收集2005年1月至2010年12月宁夏医科大学总医院确诊SLE合并心脏损害的住院患者的临床资料,以同期住院的无心脏损害的SLE患者作为对照,分析SLE心脏损害患者的临床特征;比较两组间临床和实验室检查的差异,通过Logistic回归分析初步探讨SLE心脏损害的危险因素;并通过比较两组间SLICC损伤指数(SDI)积分进一步了解其他脏器损害情况。结果在114例SLE合并心脏损害患者中,超声心动图检查异常者107例,其中心包积液45例(45/114),占39.47%,瓣膜反流41例(41/114),占35.96%,左室舒张功能减低24例(24/114),占21.01%,心脏扩大20例(20/114),占17.5%,肺动脉压升高者11例(11/114),占9.65%。心电图检查异常者47例,其中窦性心动过速27例(27/114),占23.7%,ST-T异常22例(22/114),占19.3%,房室传导阻滞5例,窦性心动过缓3例,频发室性期前收缩、频发房性期前收缩各1例。单因素分析显示,与系统性红斑狼疮患者心脏损害的相关因素包括:病程、发热、浆膜炎、神经精神狼疮、贫血、肾脏损害、SLEDAI≥10、抗Sm抗体、抗ds-DNA结合率、ANCA、补体C3、甘油三酯、高密度脂蛋白。经Logistic回归分析显示,系统性红斑狼疮患者合并心脏损害的危险因素包括:贫血、低补体C3、高密度脂蛋白降低。结论1.合并贫血、低补体C3、高密度脂蛋白降低的SLE患者易出现心脏损害。2.合并心脏损害的SLE患者其他器官损害程度也较高,需及时全面的了解SLE脏器损害情况。

论文目录

  • 摘要
  • ABSTRACT
  • 前言
  • 资料与方法
  • 结果
  • 讨论
  • 结论
  • 附图
  • 参考文献
  • 综述
  • 综述参考文献
  • 致谢
  • 攻读学位期间发表的学术论文
  • 个人简历
  • 相关论文文献

    • [1].Macrophage activation syndrome as an initial presentation of systemic lupus erythematosus[J]. World Journal of Clinical Cases 2020(11)
    • [2].The polymorphism rs13259960in SLEAR predisposes to systemic lupus erythematosus[J]. Science Foundation in China 2020(02)
    • [3].Salvianolic acid A alleviates renal injury in systemic lupus erythematosus induced by pristane in BALB/c mice[J]. Acta Pharmaceutica Sinica B 2017(02)
    • [4].Clinical characteristics of macrophage activation syndrome secondary to systemic lupus erythematosus[J]. China Medical Abstracts(Internal Medicine) 2017(01)
    • [5].The effect of long-term low dose prednisone on bone mineral density in patients with systemic lupus erythematosus[J]. China Medical Abstracts(Internal Medicine) 2017(02)
    • [6].Association analysis between TNIP1 gene polymorphisms and systemic lupus erythematosus in a Chinese Han population[J]. China Medical Abstracts(Internal Medicine) 2016(02)
    • [7].Systemic lupus erythematosus complicated by noncirrhotic portal hypertension: A case report and review of literature[J]. World Journal of Clinical Cases 2018(13)
    • [8].Effect of serum interleukin-21 on B cell secretory capacity and apoptosis in patients with systemic lupus erythematosus[J]. China Medical Abstracts(Internal Medicine) 2017(02)
    • [9].Salvianolic acid A alleviates renal injury in systemic lupus erythematosus induced by pristane in BALB/c mice[J]. 中国药理学与毒理学杂志 2016(10)
    • [10].B cells biology in systemic lupus erythematosus—from bench to bedside[J]. Science China(Life Sciences) 2015(11)
    • [11].Efficacy and safety of rituximab therapy for systemic lupus erythematosus:a systematic review and meta-analysis[J]. Journal of Zhejiang University-Science B(Biomedicine & Biotechnology) 2012(09)
    • [12].Serum IL-10 from systemic lupus erythematosus patients suppresses the differentiation and function of monocyte-derived dendritic cells[J]. Journal of Biomedical Research 2012(06)
    • [13].Ischemic colitis associated with intestinal vasculitis: Histological proof in systemic lupus erythematosus[J]. World Journal of Gastroenterology 2008(22)
    • [14].CSF Brain-Reactive Autoantibodies are Elevated in Patients with Viral Encephalitis[J]. Neuroscience Bulletin 2020(08)
    • [15].Orthopedic surgery and its complication in systemic lupus erythematosus[J]. World Journal of Orthopedics 2014(01)
    • [16].Gastrointestinal involvement in systemic lupus erythematosus:Insight into pathogenesis, diagnosis and treatment[J]. World Journal of Gastroenterology 2010(24)
    • [17].Modified Zhibai Dihuang pill, a traditional Chinese medicine formula, on steroid withdrawal in systemic lupus erythematosus: A systematic review and meta-analysis[J]. Journal of Integrative Medicine 2020(06)
    • [18].Pathological significance and regulatory mechanism of lymphotoxin β receptor overexpression in T cells of patients with systemic lupus erythematosus[J]. The Journal of Biomedical Research 2018(02)
    • [19].Identification of human cytomegalovirus phosphoprotein 65 in C57BL/6 and BXSB mice as a potential trigger of systemic lupus erythematosus related serum markers[J]. Asian Pacific Journal of Tropical Biomedicine 2015(02)
    • [20].系统性红斑狼疮患者认知功能障碍及相关危险因素[J]. 中国神经精神疾病杂志 2019(12)
    • [21].Allergy and Immunology[J]. China Medical Abstracts(Internal Medicine) 2014(04)
    • [22].Autoimmune Disease[J]. China Medical Abstracts(Internal Medicine) 2009(02)
    • [23].Advances in Diagnosis and Treatment of Neuropsychiatric Systemic Lupus Erythematosus[J]. 临床医学工程 2017(S1)
    • [24].特发性甲状旁腺功能减退合并系统性红斑狼疮一例[J]. 郑州大学学报(医学版) 2017(01)
    • [25].系统性红斑性狼疮妇女怀孕比想象中安全[J]. 基础医学与临床 2016(03)
    • [26].皮肤型红斑狼疮诊疗新进展[J]. 皮肤病与性病 2016(05)
    • [27].Challenge of liver disease in systemic lupus erythematosus:Clues for diagnosis and hints for pathogenesis[J]. World Journal of Hepatology 2014(06)
    • [28].Connective Tissue Disorder[J]. China Medical Abstracts(Internal Medicine) 2008(04)
    • [29].Effect of interleukin-21 and dexamethasone on follicular helper T cells in patients with systemic lupus erythematosus[J]. China Medical Abstracts(Internal Medicine) 2013(04)
    • [30].Tu Youyou: China's First Nobel PrizLaureate in Medicine[J]. China Today 2019(09)

    标签:;  ;  ;  

    系统性红斑狼疮心脏损害的临床及危险因素分析
    下载Doc文档

    猜你喜欢